TrialBlood2013

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

Daniel H Fowler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.